KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Non-Current Debt (2016 - 2025)

Historic Non-Current Debt for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to $63.0 billion.

  • AbbVie's Non-Current Debt rose 762.62% to $63.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $63.0 billion, marking a year-over-year increase of 762.62%. This contributed to the annual value of $60.3 billion for FY2024, which is 1560.72% up from last year.
  • As of Q3 2025, AbbVie's Non-Current Debt stood at $63.0 billion, which was up 762.62% from $63.0 billion recorded in Q2 2025.
  • AbbVie's 5-year Non-Current Debt high stood at $74.2 billion for Q2 2021, and its period low was $52.2 billion during Q4 2023.
  • Moreover, its 5-year median value for Non-Current Debt was $61.0 billion (2022), whereas its average is $62.4 billion.
  • In the last 5 years, AbbVie's Non-Current Debt soared by 1722.24% in 2021 and then plummeted by 1843.37% in 2022.
  • AbbVie's Non-Current Debt (Quarter) stood at $64.2 billion in 2021, then dropped by 7.87% to $59.1 billion in 2022, then dropped by 11.74% to $52.2 billion in 2023, then grew by 15.61% to $60.3 billion in 2024, then grew by 4.36% to $63.0 billion in 2025.
  • Its Non-Current Debt was $63.0 billion in Q3 2025, compared to $63.0 billion in Q2 2025 and $64.5 billion in Q1 2025.